| 12396944 |
Injectable buprenorphine formulation |
Fredrik Tiberg, Markus Johnsson |
2025-08-26 |
| 12318379 |
Opioid formulations |
Fredrik Tiberg, Markus Johnsson |
2025-06-03 |
| 12161640 |
Opioid formulations |
Fredrik Tiberg, Markus Johnsson |
2024-12-10 |
| 12029813 |
Injectable buprenorphine formulation |
Fredrik Tiberg, Markus Johnsson |
2024-07-09 |
| 11135215 |
Opioid formulations |
Fredrik Tiberg, Markus Johnsson |
2021-10-05 |
| 11110084 |
Opioid formulations |
Fredrik Tiberg, Markus Johnsson |
2021-09-07 |
| 10912772 |
Opioid formulations |
Fredrik Tiberg, Markus Johnsson |
2021-02-09 |
| 9937164 |
Opioid formulations |
Fredrik Tiberg, Markus Johnsson |
2018-04-10 |
| 8545832 |
Lipid depot formulations |
Krister Thuresson, Fredrik Tiberg, Markus Johansson, Fredrik Joabsson, Markus Johnsson |
2013-10-01 |
| 8236292 |
Liquid depot formulations |
Krister Thuresson, Fredrik Tiberg, Markus Johansson, Fredrik Joabsson, Markus Johnsson |
2012-08-07 |
| 8236755 |
Opioid depot formulations |
Krister Thuresson, Fredrik Tiberg, Markus Johansson, Fredrik Joabsson, Markus Johnsson |
2012-08-07 |
| 7143765 |
Inhalation device |
Lars Asking, Mikael Jonströmer |
2006-12-05 |
| 5979479 |
Use of alkoxylated alkanolamide together with alkoxylated alcohol as a friction-reducing agent |
Martin Hellsten |
1999-11-09 |
| 5911236 |
Alkoxylated alkanolamide together with an ionic surfactant as friction-reducing agent |
Martin Hellsten, Carina Brink |
1999-06-15 |
| 5902784 |
Use of a betaine surfactant together with an anionic surfactant as a drag-reducing agent |
Martin Hellsten |
1999-05-11 |
| 5700766 |
Use of an amphoteric surfactant as a friction-reducing agent |
Martin Hellsten |
1997-12-23 |
| 5339855 |
Use of alkoxylated alkanolamide as friction-reducing agent |
Martin Hellsten |
1994-08-23 |